About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group of Physiology and Pathophysiology of the Digestive Tract focuses its research activity on the functioning of the digestive tract as a whole, including the functions of secretion, motility, absorption and barrier both in healthy individuals and in the presence of disease. The application of knowledge to clinical practice is a priority for the group.
Research in digestive motility encompasses disorders of visceral sensitivity, the brain-gut axis and intestinal allergy. Research on inflammation also includes the pancreas.
We have also launched a cross-sectional research program that focuses on the role of the gut microbiota in inflammation and gut function.
IP: José García Arumí Collaborators: María Antolín Mate, Anna Duarri Piqué, Claudia Garcia-Arumí Fusté, Miguel Angel Zapata Victori, Laura Natalia Distefano, Maddalen Zufiaurre Seijo Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI22/01747 Duration: 01/01/2023 - 31/12/2025
IP: Jorge Serra Pueyo Collaborators: Ariadna Aguilar Cayuelas, Anna Beneria González, Claudia Barber Caselles, Luis Gerardo Alcala Gonzalez Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI22/00618 Duration: 01/01/2023 - 31/12/2025
IP: - Collaborators: Laura Campderros Traver, Eva Polverino Funding agency: Instituto de Salud Carlos III Funding: 147620 Reference: PI22/00887 Duration: 01/01/2023 - 31/12/2025
IP: Fco Javier Santos Vicente Collaborators: Beatriz Lobo Alvarez, Silvia Muñoz Caller, Carmen Alonso Cotoner, Natalia Rodriguez Santas, Ana Maria Gonzalez Castro, Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (D, Marc Pigrau Pastor, Adoración Nieto Ruiz, Alejandro Henao Paez, Consuelo Cammarota , José Alegre Martin, Jesus Castro Marrero, Marta Ribases Haro, Natalia Llonga Tejedor, Amanda Rodríguez Urrutia Funding agency: EUROPEAN COMMISSION Funding: 1148684.84 Reference: DISCOVERIE_H2020-SC1-BHC2019 Duration: 01/01/2020 - 31/05/2025
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
The European project DISCOvERIE, led by Vall d’Hebron, paves the way for more personalized diagnoses and new treatment strategies to improve patients’ quality of life.
15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.
